13 July 2020 - First and only digital rescue inhaler with built-in sensors now available by prescription to patients in the U.S.

Teva Respiratory, a U.S. affiliate of Teva Pharmaceutical Industries, today announced the launch of ProAir Digihaler (albuterol sulphate 117 mcg) inhalation powder, the first and only digital rescue inhaler indicated in patients four years or older for the treatment or prevention of bronchospasm who have reversible obstructive airway disease, and for prevention of exercise-induced bronchospasm. 

The device features built-in Bluetooth Wireless Technology sensors, which connect to a companion mobile app and provide inhaler event information.

Read Teva Pharmaceuticals press release